Impact of hypoglycemic agents on glycemic control and cognitive decline in older adults with type 2 diabetes: real-world evidence on glucagon like peptide 1 receptor agonists

Benedetta DI MARZIO, Giulia GASPARINI, Andrea AMBROSIO, Alessandra COIN, Luca FILIPPONI, Giovanni SARTORE, Elisabetta FERRA, Mario V. PAPA, Adele RAVELLI, Chiara CEOLIN, Marina DE RUI, Bruno M. ZANFORLINI, Chiara CURRERI, Anna BERTOCCO, Maria DEVITA, Giuseppe SERGI

Open source

DOI: 10.23736/s2724-6507.26.04501-x
Published: 2026-09
Container: Minerva Endocrinology
Publisher: Edizioni Minerva Medica
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.23736/s2724-6507.26.04501-x,
  title = {Impact of hypoglycemic agents on glycemic control and cognitive decline in older adults with type 2 diabetes: real-world evidence on glucagon like peptide 1 receptor agonists},
  author = {Benedetta DI MARZIO and Giulia GASPARINI and Andrea AMBROSIO and Alessandra COIN and Luca FILIPPONI and Giovanni SARTORE and Elisabetta FERRA and Mario V. PAPA and Adele RAVELLI and Chiara CEOLIN and Marina DE RUI and Bruno M. ZANFORLINI and Chiara CURRERI and Anna BERTOCCO and Maria DEVITA and Giuseppe SERGI},
  year = {2026},
  journal = {Minerva Endocrinology},
  doi = {10.23736/s2724-6507.26.04501-x},
  url = {https://doi.org/10.23736/s2724-6507.26.04501-x}
}

RIS

TY  - JOUR
TI  - Impact of hypoglycemic agents on glycemic control and cognitive decline in older adults with type 2 diabetes: real-world evidence on glucagon like peptide 1 receptor agonists
AU  - Benedetta DI MARZIO
AU  - Giulia GASPARINI
AU  - Andrea AMBROSIO
AU  - Alessandra COIN
AU  - Luca FILIPPONI
AU  - Giovanni SARTORE
AU  - Elisabetta FERRA
AU  - Mario V. PAPA
AU  - Adele RAVELLI
AU  - Chiara CEOLIN
AU  - Marina DE RUI
AU  - Bruno M. ZANFORLINI
AU  - Chiara CURRERI
AU  - Anna BERTOCCO
AU  - Maria DEVITA
AU  - Giuseppe SERGI
PY  - 2026
JO  - Minerva Endocrinology
DO  - 10.23736/s2724-6507.26.04501-x
UR  - https://doi.org/10.23736/s2724-6507.26.04501-x
ER  -

APA

MARZIO, B. D., GASPARINI, G., AMBROSIO, A., COIN, A., FILIPPONI, L., SARTORE, G., FERRA, E., PAPA, M. V., RAVELLI, A., CEOLIN, C., RUI, M. D., ZANFORLINI, B. M., CURRERI, C., BERTOCCO, A., DEVITA, M., & SERGI, G. (2026). Impact of hypoglycemic agents on glycemic control and cognitive decline in older adults with type 2 diabetes: real-world evidence on glucagon like peptide 1 receptor agonists. Minerva Endocrinology. https://doi.org/10.23736/s2724-6507.26.04501-x

Source records

crossref · retrieved 2026-09-25T11:59:35.965Z